Latest News
Read more news
-
Semen Analysis Service Cessation 26 March 2024 Please be informed that effective 14 April 2024, PathWest Anatomical Pathology will no longer offer fertility analysis on semen samples, including samples pertaining to vasectomy reversal. Please note that PathWest will continue to offer semen analysis for post-vasectomy samples. For this, please ensure that patients are advised of the following: Metro patients: samples should be delivered to PathWest, QEII Medical Centre, J Block within one hour of collection – Monday to Friday from 8am-3pm (post- vasectomy samples only). Regional patients: samples should be delivered to a PathWest collection centre within one hour of collection – Monday to Thursday only (post-vasectomy samples only). If you wish to refer patients for fertility testing, they may submit samples to any of the following specialised collection and testing facilities: Concept Fertility Centre ... -
Biochemistry FSH Consultant Chemical Pathologist becomes the Editor-in-Chief of RCPA’s Journal 15 March 2024 Congratulations to Dr John Burnett on his appointment as the new Editor-in-Chief of the Royal College of Pathologists of Australasia (RCPA) Pathology Journal, announced at the RCPA Pathology Update 2024 Editorial Board Meeting. Read RCPA’s post on LinkedIn for more information. -
Rare Disease Day 2024 15 March 2024 Rare Disease Day is celebrated globally on 29 February 2024 raising awareness to improve the access to diagnosis and treatment for those living with a rare disease, their families and carers. At PathWest, we have organised a number of events to acknowledge the significance of this day, highlighting the outstanding work of our teams in paving the way for scientific advancement, treatment and a brighter future for those affected by rare diseases. Joined by our guest speaker, Andrew Bannister, Ambassador of Rare Voices Australia, our Chief Executive Dr Narelle Hadlow, Board Chair Ms Angie Paskevicius, Diagnostic Genomics Head of Department Dr Dimitar Azmanov, Board Member Mr Tony Vis, Acting Chief Pathologist Dr David Smith, Biochemistry QEII Head of Department Dr Simon Carrivick and other PathWest staff, we not only recognise the rarity of these diseases but also the strength, courage, a... -
Immunosuppressant service changes to 7 days per week starting on 7 January 2024 06 February 2024 PathWest has commenced the seven-day-per-week immunosuppressant service. Registrars will be exempt from the obligation to contact the on-call pathologists at PathWest to obtain authorisation to send samples on weekends.To facilitate an efficient workflow and assure prompt delivery of service, please note the following sample processing times and kindly distribute this information to other staff members. To obtain same day results (by 4 pm) for Tacrolimus, Sirolimus, Everolimus, and Cyclosporin test requests, samples must be received in testing laboratory (CBPT, QEII MC, Level 1, PP Block, Hospital Avenue, Nedlands, WA 6009): Monday - Saturday by 2pm, and Sundays/public holidays by 1pm. Please note: Specimens received after 2pm Monday – Saturday and after 1pm Sundays and public holidays will be assayed and reported the following day Critically urgent Tacrolimus ...
-
Pioneering cancer advancements - PathWest's collaborative initiatives on World Cancer Day 05 February 2024 World Cancer Day, observed annually on 4 February, serves as a reminder of the global collaboration essential in the ongoing battle against cancer. At the forefront of this collaborative effort is the PathWest Community Health and Hospital Program, spearheading a $19 million initiative in Western Australia dedicated to Comprehensive Genomic Profiling (CGP) for all cancer patients. This ground-breaking endeavour leverages state-of-the-art massively parallel sequencing technology, marking a significant stride in the pursuit of advanced cancer diagnosis and treatment. CGP is an integral aspect of the program which serves as a transformative tool that identifies biomarkers, guiding tailored treatment strategies and instilling hope for those facing exhaustive conventional treatment options. The program's commitment extends to ensuring equitable cancer care for all Western Australian patients...
Last Updated:
20/05/2025